For patients facing terminal illnesses who have exhausted all approved treatment options, compassionate use offer a crucial lifeline of hope. These programs, also known as expanded access programs provide a pathway for patients to receive experimental treatments that haven’t yet completed the full FDA approval process but show promise in early clinical trials. The journey through terminal illness is often marked by a race against time. While the traditional drug approval process is necessarily rigorous […]
